Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ (2016) Assessing the prognostic significance of histologic response in osteosarcoma: a comparison of outcomes on CCG-782 and INT0133-a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 63(10):1737–1743. https://doi.org/10.1002/pbc.26034

Article  PubMed Central  PubMed  Google Scholar 

Fletcher BD (1991) Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR Am J Roentgenol 157(4):825–833. https://doi.org/10.2214/ajr.157.4.1892044

Article  CAS  PubMed  Google Scholar 

Smith J, Heelan RT, Huvos AG, Caparros B, Rosen G, Urmacher C, Caravelli JF (1982) Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients. Radiology 143(2):355–360. https://doi.org/10.1148/radiology.143.2.6978499

Article  CAS  PubMed  Google Scholar 

Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG (1979) Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43(6):2163–2177. https://doi.org/10.1002/1097-0142(197906)43:6%3c2163::aid-cncr2820430602%3e3.0.co;2-s

Article  CAS  PubMed  Google Scholar 

Salzer-Kuntschik M, Delling G, Beron G, Sigmund R (1983) Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80. J Cancer Res Clin Oncol 106(Suppl):21–24. https://doi.org/10.1007/BF00625047

Article  PubMed  Google Scholar 

Fonseca A, Ryan AL, Gibson P, Hendershot E, Hopyan S, Ranson M, Stimec J, Gupta AA (2020) Radiological assessment and outcome of local disease progression after neoadjuvant chemotherapy in children and adolescents with localized osteosarcoma. J Clin Med 9 (12). https://doi.org/10.3390/jcm9124070

Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, Brach Del Prever A, Mancini A, Gherlinzoni F, Padovani G, et al. (1990) Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 65 (11):2539-2553. https://doi.org/10.1002/1097-0142(19900601)65:11<2539::aid-cncr2820651125>3.0.co;2-m

Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F (2011) Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer. Ann Surg Oncol 18(4):932–938. https://doi.org/10.1245/s10434-010-1390-8

Article  PubMed Central  PubMed  Google Scholar 

Nozawa K, Takatsuka D, Endo Y, Horisawa N, Ozaki Y, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H (2022) Impact of tumor progression on survival during neoadjuvant chemotherapy in breast cancer: a cohort study. Anticancer Res 42(7):3735–3742. https://doi.org/10.21873/anticanres.15863

Article  CAS  PubMed  Google Scholar 

Paniccia A, Gleisner AL, Zenati MS, Al Abbas AI, Jung JP, Bahary N, Lee KKW, Bartlett D, Hogg ME, Zeh HJ, Zureikat AH (2020) Predictors of disease progression or performance status decline in patients undergoing neoadjuvant therapy for localized pancreatic head adenocarcinoma. Ann Surg Oncol 27(8):2961–2971. https://doi.org/10.1245/s10434-020-08257-4

Article  PubMed  Google Scholar 

Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240 (6):1052-1061; discussion 1061-1054 https://doi.org/10.1097/01.sla.0000145964.08365.01

Kleinerman ES (2014) Current advances in osteosarcoma. Springer, New York

Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C (1993) Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72 (11):3227-3238 https://doi.org/10.1002/1097-0142(19931201)72:11<3227::aid-cncr2820721116>3.0.co;2-c

Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M, Campanacci M (2000) Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 18(24):4016–4027. https://doi.org/10.1200/JCO.2000.18.24.4016

Article  CAS  PubMed  Google Scholar 

Whelan JS, Jinks RC, McTiernan A, Sydes MR, Hook JM, Trani L, Uscinska B, Bramwell V, Lewis IJ, Nooij MA, van Glabbeke M, Grimer RJ, Hogendoorn PC, Taminiau AH, Gelderblom H (2012) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 23(6):1607–1616. https://doi.org/10.1093/annonc/mdr491

Article  CAS  PubMed  Google Scholar 

Yasin NF, Abdul Rashid ML, Ajit Singh V (2020) Survival analysis of osteosarcoma patients: a 15-year experience. J Orthop Surg (Hong Kong) 28(1):2309499019896662. https://doi.org/10.1177/2309499019896662

Article  PubMed  Google Scholar 

Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kuhne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM (2013) Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol 31(18):2303–2312. https://doi.org/10.1200/JCO.2012.43.8598

Article  PubMed  Google Scholar 

Ganguly S, Sasi A, Khan SA, Kumar VS, Kapoor L, Sharma MC, Mridha A, Barwad A, Thulkar S, Pushpam D, Bakhshi S (2023) Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients. Front Oncol 13:1148480. https://doi.org/10.3389/fonc.2023.1148480

Article  PubMed Central  PubMed  Google Scholar 

Xin S, Wei G (2020) Prognostic factors in osteosarcoma: a study level meta-analysis and systematic review of current practice. J Bone Oncol 21:100281. https://doi.org/10.1016/j.jbo.2020.100281

Article  PubMed Central  PubMed  Google Scholar